Thompson Davis & Co’s Myomo MYO Stock Holding History

Thompson Davis & Co’s Portfolio MYO Stock Details MYO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-53,600	Closed	-$258K	–	157
2025 Q1	$258K	Buy	53,600 +25,450	+90%	+$145K	0.2%	81
2024 Q4	$181K	Buy	+28,150	New	+$137K	0.12%	106

Other funds holding MYO

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JAG

Journey Advisory Group Covington, Kentucky $1.31B AUM 24.92% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Thompson Davis & Co's MYO Position: Q2 2025 in Review

Thompson Davis & Co sold out of Myomo (MYO) in Q2 2025, closing a stake of 53,600 shares — an estimated $258K sold.

Thompson Davis & Co first reported a position in MYO in Q4 2024 and held it in 2 quarters. The position peaked at $258K in Q1 2025. 82 funds tracked by Wall St. Rank hold MYO as of Q2 2025.

Thompson Davis & Co reported no remaining Myomo position as of Q2 2025 after selling out during the quarter.
Thompson Davis & Co sold 53,600 Myomo shares in Q2 2025, an estimated $258K.
Thompson Davis & Co first reported a position in Myomo in Q4 2024 and held it in 2 quarters.
Thompson Davis & Co's Myomo position peaked at $258K in Q1 2025.
82 funds tracked by Wall St. Rank held Myomo as of Q2 2025.

Based on Thompson Davis & Co's 13F filing for Q2 2025, filed 8 Aug 2025.